Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

NCT06943664 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Roswell Park Cancer Institute

Collaborators